What is the price target for CVNA stock?
32 analysts have analysed CVNA and the average price target is 425.87 USD. This implies a price increase of 4.1% is expected in the next year compared to the current price of 409.08.
NYSE:CVNA • US1468691027
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CARVANA CO (CVNA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-21 | B of A Securities | Maintains | Neutral -> Neutral |
| 2026-04-09 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-04-07 | Barclays | Maintains | Overweight -> Overweight |
| 2026-04-06 | B of A Securities | Downgrade | Buy -> Neutral |
| 2026-03-16 | Needham | Reiterate | Buy -> Buy |
| 2026-02-20 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-20 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-19 | DA Davidson | Maintains | Neutral -> Neutral |
| 2026-02-19 | BTIG | Maintains | Buy -> Buy |
| 2026-02-19 | Deutsche Bank | Maintains | Buy -> Buy |
| 2026-02-19 | Needham | Reiterate | Buy -> Buy |
| 2026-02-19 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-19 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2026-02-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-19 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-19 | B of A Securities | Maintains | Buy -> Buy |
| 2026-01-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-21 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-15 | BTIG | Maintains | Buy -> Buy |
| 2026-01-14 | UBS | Maintains | Buy -> Buy |
| 2026-01-13 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-23 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-12-19 | BTIG | Reiterate | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.771B -20.82% | 13.673B 26.94% | 20.322B 48.63% | 27.366B 34.66% | 33.763B 23.38% | 40.691B 20.52% | 48.91B 20.20% | 59.037B 20.71% | 76.518B 29.61% | 91.637B 19.76% | 109.771B 19.79% | |
| EBITDA YoY % growth | 288M 123.19% | 1.295B 349.65% | 2.156B 66.49% | 2.955B 37.06% | 3.844B 30.08% | 4.764B 23.93% | 5.595B 17.44% | 7.337B 31.13% | 9.235B 25.87% | 11.256B 21.88% | 13.716B 21.86% | |
| EBIT YoY % growth | -64M 95.74% | 990M 1,646.88% | 1.881B 90.00% | 2.618B 39.18% | 3.483B 33.04% | 4.359B 25.15% | 5.173B 18.67% | 6.11B 18.11% | 8.732B 42.91% | 15.81B 81.06% | 18.666B 18.06% | |
| Operating Margin | -0.59% | 7.24% | 9.26% | 9.57% | 10.32% | 10.71% | 10.58% | 10.35% | 11.41% | 17.25% | 17.00% | |
| EPS YoY % growth | -3.52 53.19% | 1.57 144.60% | 4.88 210.83% | 7.34 50.32% | 10.30 40.39% | 12.84 24.67% | 16.24 26.47% | 11.53 -29.02% | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.44 -4.83% | 1.84 43.49% | 2.02 96.34% | 1.69 59.75% | 2.39 66.44% | 2.80 52.45% | 2.95 45.77% | 2.57 51.49% | 3.14 31.34% | 3.42 22.04% | 3.67 24.57% | 3.24 26.44% |
| Revenue Q2Q % growth | 6.172B 45.84% | 6.685B 38.12% | 7.294B 29.17% | 7.205B 28.59% | 7.816B 26.64% | 8.312B 24.34% | 8.965B 22.91% | 8.803B 22.18% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 658.24M 40.95% | 761.35M 16.77% | 814.21M 7.42% | 725.92M 3.85% | 910.42M 38.31% | 1.011B 32.79% | 1.053B 29.33% | 971.62M 33.85% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 564.02M 43.15% | 673.47M 31.79% | 733.43M 32.87% | 642.8M 51.60% | 753.13M 33.53% | 881.45M 30.88% | 949.18M 29.42% | 836.2M 30.09% | N/A | N/A | N/A | N/A |
All data in USD
32 analysts have analysed CVNA and the average price target is 425.87 USD. This implies a price increase of 4.1% is expected in the next year compared to the current price of 409.08.
CARVANA CO (CVNA) will report earnings on 2026-04-29, after the market close.
The consensus EPS estimate for the next earnings of CARVANA CO (CVNA) is 1.44 USD and the consensus revenue estimate is 6.17B USD.
The expected long term growth rate for CARVANA CO (CVNA) is 25.89%.